Accenture (NYSE:ACN) has been named an inaugural AI Specialization partner by NiCE. The company is expanding AI focused partnerships, including work w...
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” first-quarter 2026 investor lette...
A Swedish court has ordered Google to pay 14.3 billion Swedish kronor plus interest (€1.7bn) in damages to PriceRunner, the price-comparison service o...
Interactive Brokers Group launched Korean equities trading for global clients via Nextrade, South Korea's first Alternative Trading System. The rollou...
The first quarter of 2026 was characterized by elevated geopolitical risk and accelerating AI-driven disruption across the software sector and its inc...
Micron, FormFactor, Texas Instruments and Taiwan Semiconductor are highlighted as semiconductor stocks poised to benefit from rising AI infrastructure...
Gold fell 24% during the 2025 Iran warâwas it really a safe haven? Reassess goldâs true role, dollar myths, and diversification for 2026.
U.S. lawmakers have opened a national security probe into Eli Lilly's (NYSE:LLY) clinical trial activities in China. The House Select Committee on Chi...
Meta stock rallied on a report that the Facebook parent plans to offer access to its massive AI cloud infrastructure to business customers.
The company is weighing plans to sell access to AI models and raw computing capacity, setting up new competition with AWS, Azure, and Google Cloud
Women's sports continues its period of strong growth.
Martin Marietta Materials is back in focus after analysts trimmed their fair value estimate from US$700.04 to US$683.09, a modest reset that has caugh...
MSC Industrial (NYSE: MSM) stock hits a new 52-week high after Q3 earnings beat Wall Street estimates and revenue jumps 7.8%.
United Parcel Service stock has fallen about 36.2% over the past five years, yet the current valuation work suggests the market price may still sit we...
RBB (RBB) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Nuvectis Pharma is downgraded from 'Strong Buy' to 'Hold' due to disappointing NXP800 data and increased execution risk. Click here to read my analysi...
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” first-quarter 2026 investor lette...
On June 27, 2026, Zoetis Inc. was removed from several Russell Top 200 indexes and simultaneously added to the Russell Midcap Index and its value and ...
Loading...